GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Body and Mind Inc (XCNQ:BAMM) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Body and Mind (XCNQ:BAMM) Total Revenue Growth Rate (Future 3Y To 5Y Est) : N/A (As of Jun. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Body and Mind Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.


Competitive Comparison of Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Drug Manufacturers - Specialty & Generic subindustry, Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



Body and Mind  (XCNQ:BAMM) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Body and Mind Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Body and Mind's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


Body and Mind (XCNQ:BAMM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Body and Mind Inc (XCNQ:BAMM) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)
Traded in Other Exchanges
Address
750-1095 West Pender Street, Vancouver, BC, CAN, V6E 2M6
Body and Mind Inc is a multi-state cannabis operator, which has retail, distribution, cultivation, and/or processing operations in Nevada, California, Arkansas, Ohio and Illinois. It has developed the marquis lifestyle Body and Mind brand in Nevada with penetration into dispensaries and has expanded its brand and products to dispensaries in California. The Body and Mind brand appeals to a wide range of cannabis consumers with products including flowers, oils, extracts (wax, live resin, ambrosia), and edibles. The Company Operates in Three segments; Wholesale, Retail, and All others. The Majority of revenue is derived from the Retail segment.
Executives
Darren Tindale Senior Officer

Body and Mind (XCNQ:BAMM) Headlines

From GuruFocus

Books-A-Million: All About Intentions

By Barel Karsan Barel Karsan 03-28-2011

Books-A-Million - The Anderson Family Turnaround Opportunity

By windplayer13 windplayer13 12-06-2014

BooksAMillion Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 06-10-2010

BooksAMillion Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 09-09-2010